Last year, Axsome Therapeutics Inc generated 507.09M USD for its biggest-performing segment, Auvelitv. The United States made the largest contribution, accounting for 628.62M USD last year. For the latest quarter, Axsome Therapeutics Inc reported the revenue of 180.28M USD for the period ending 2026-06-30, which came from the top-performing segment, Auvelitv. United States contributed the highest revenue, at 215.37M USD.

By Business

Revenue

Proportion

Annual

Annual

Quarterly

Auvelitv

Sunosi

Symbravo

Sunosi royality revenue

Sunosi License revenue

FY2025

FY2024

FY2023

Auvelitv

507.09M(79.42%)

291.38M(75.55%)

130.07M(48.07%)

Sunosi

120.09M(18.81%)

90.30M(23.41%)

72.39M(26.75%)

Symbravo

6.61M(1.04%)

--(--)

Sunosi royality revenue

4.70M(0.74%)

4.02M(1.04%)

2.40M(0.89%)

Sunosi License revenue

--(--)

65.73M(24.29%)

By Region

Revenue

Proportion

Annual

Annual

Quarterly

United States

Outside of the United States

United States

FY2025

FY2024

FY2023

United States

628.62M(98.45%)

--(--)

Outside of the United States

9.88M(1.55%)

7.53M(1.95%)

73.38M(27.12%)

United States

--(--)

378.16M(98.05%)

197.22M(72.88%)